PPARG and the PTEN-PI3K/AKT Signaling Axis May Cofunction in Promoting Chemosensitivity in Hypopharyngeal Squamous Cell Carcinoma
Open Access
- 11 March 2024
- journal article
- research article
- Published by Wiley in PPAR Research
- Vol. 2024, 1-8
Abstract
It has been demonstrated that PPARG may interact with the PTEN-PI3K/AKT pathway, contributing to its involvement in the chemotherapy treatment of hypopharyngeal squamous cell carcinoma (HSCC). However, the underlying mechanism remains largely unknown. In this study, gene expression profiles of 17 HSCC patients, comprising 8 chemotherapy-sensitive patients (CSP) and 9 chemotherapy-nonsensitive patients (CNSP), were collected and analyzed to investigate expression patterns, correlations, influencing factors of the PPARG-PTEN-PI3K/AKT pathway, and its role in regulating chemosensitivity. The results revealed significantly increased expression ( ) of AKT1, AKT2, AKT3, PIK3CA, PPARG, and PTEN in the CSP group compared to the CNSP group. Specifically, AKT2 exhibited significant overexpression in tumor tissue ( ), while AKT2, AKT3, PPARG, and PTEN displayed significant increases in normal tissue ( ). Positive correlations ( , ) were observed between PIK3CA, AKT1, AKT2, AKT3, and PTEN, with AKT2, AKT3, and PTEN also showing significant correlations with PPARG ( , ). Age, gender, and disease stage had no influence on PPARG, PIK3CA, and PTEN expression, but they may affect AKT expressions. Pathway analysis revealed that PPARG may interact with the PTEN-PI3K/AKT signaling pathway, playing a crucial role in regulating chemosensitivity in the normal tissue microenvironment. Our results suggest that AKT1 and PIK3CA may be associated with chemosensitivity in HSCC tumor cells, while PPARG and PTEN might exhibit a correlation with a specific segment of the PI3K/AKT pathway, potentially influencing chemosensitivity in the normal tissue microenvironment of HSCC patients.Keywords
Funding Information
- Capital Health Research and Development of Special (2022–1–2051, 2020YFB1312805, KM202210025014, QML20210203)
- National Key Research and Development Program of China (2022–1–2051, 2020YFB1312805, KM202210025014, QML20210203)
- Beijing Municipal Education Commission (2022–1–2051, 2020YFB1312805, KM202210025014, QML20210203)
- Beijing Municipal Administration of Hospitals (2022–1–2051, 2020YFB1312805, KM202210025014, QML20210203)
This publication has 39 references indexed in Scilit:
- Meta-analysis of Transcriptomic Data from Lung Autopsy and Cellular Models of SARS-CoV-2 InfectionBiochemical Genetics, 2023
- Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidenceCancer Letters, 2023
- Uncovering the molecular mechanisms of Fructus Choerospondiatis against coronary heart disease using network pharmacology analysis and experimental pharmacologyAnalytical Biochemistry, 2023
- BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosisCancer Medicine, 2023
- RETRACTED ARTICLE: Molecular mechanism study and tumor heterogeneity of Chinese angelica and Fructus aurantii in the treatment of colorectal cancer through computational and molecular dynamicsFunctional & Integrative Genomics, 2023
- Discovery of potential quality markers of Fritillariae thunbergii bulbus in pneumonia by combining UPLC-QTOF-MS, network pharmacology, and molecular dockingMolecular Diversity, 2023
- Machine learning-based models for genomic predicting neoadjuvant chemotherapeutic sensitivity in cervical cancerBiomedicine & Pharmacotherapy, 2023
- Identification of molecular subtypes based on chromatin regulator and tumor microenvironment infiltration characterization in papillary renal cell carcinomaJournal of Cancer Research and Clinical Oncology, 2022
- Identification of crucial hub genes and potential molecular mechanisms in breast cancer by integrated bioinformatics analysis and experimental validationComputers in Biology and Medicine, 2022
- Alteration of PPAR‐GAMMA (PPARG; PPARγ) and PTEN gene expression in acute myeloid leukemia patients and the promising anticancer effects of PPARγ stimulation using pioglitazone on AML cellsMolecular Genetics & Genomic Medicine, 2021